Dr. Steven Teitelbaum becomes the first plastic surgeon in southern California to offer breakthrough HydraSolve™ liposuction treatment from Andrew Technologies
IRVINE, Calif., May 21, 2013 /PRNewswire/ -- Andrew Technologies announces the first availability of the HydraSolve™ Lipoplasty System in Southern California, where Dr. Steven Teitelbaum at 1301 20th St #350 in Santa Monica www.drteitelbaum.com has incorporated the device into his exclusive practice for several months and says his patients have been "thrilled" with the results.
HydraSolve™ is a novel liposuction device based on the same patented Tissue Liquefaction Technology™ that was launched in 2003 for precision cataract surgery. HydraSolve™ liquefies unwanted fat with a mist of warmed saline. This gentle instrument does not have the typical sharp edges which cause pain and bruising. The instrument glides through the liquefied fat, which allows the surgeon to concentrate on beautifully shaping their patients' figures.
Dr. Mark S. Andrew, Founder and Chief Scientific Officer of Andrew Technologies stated, "Dr. Teitelbaum is one of the most highly regarded plastic surgeons in the United States. He is on the forefront of evaluating new technologies, and is known for embracing technologies only when there is excellent data. As he said, 'I only tried HydraSolve™ after being satisfied with the thoroughness of their preclinical testing, and was impressed with the control it gave me during surgery and the improved recovery and beautiful results I saw in my patients.' So we are quite thrilled to have him choose our technology for his patients."
Dr. Steven Teitelbaum has been in practice in Santa Monica since 1995, and is an Associate Clinical Professor of Plastic Surgery at the UCLA School of Medicine. He is widely respected as a gifted surgeon and thought leader in plastic surgery. Dr. Teitelbaum received his medical education at UCLA School of Medicine and completed his surgical residencies at Harvard and the University of Southern California. He has lectured to plastic surgeons around the world about new technologies, has participated in many clinical research trials, and holds leadership positions in many of the most important plastic surgery organizations.
"HydraSolve™ has been the most intriguing advance during my two decade experience with liposuction," says Dr. Teitelbaum. "I need a tool that has unquestionable safety and allows for surgical finesse. My patients have been unanimously thrilled with their results using this state-of-the-art technology."
About Andrew Technologies, LLC
Andrew Technologies, founded in 2007, is a medical technology company committed to improving patients' lives through body aesthetics and pursuit of surgical applications of Tissue Liquefaction Technology. Andrew Technologies is a venture capital funded company based in Orange County, CA and Haddonfield, NJ. Our primary investors are WFD Ventures http://www.wfdventures.com/ and NJTC Venture Fund http://www.njtcvc.com/.
SOURCE Andrew Technologies